Cargando…
Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
Epidermal growth factor receptor (EGFR) was studied in ovarian tumours with immunohistochemical (IH) and ligand-binding assay (LBA). Two different monoclonal antibodies (MoAbs: 2E9, EGFR1) with respect to detecting EGFR with different ligand-binding affinities (low, high and low) were used. When com...
Autores principales: | Henzen-Logmans, S. C., Berns, E. M., Klijn, J. G., van der Burg, M. E., Foekens, J. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978035/ https://www.ncbi.nlm.nih.gov/pubmed/1457340 |
Ejemplares similares
-
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
por: Schuyer, M., et al.
Publicado: (1996) -
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001) -
Stromal influences on breast cancer cell growth.
por: van Roozendaal, C. E., et al.
Publicado: (1992) -
Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.
por: Abeln, E. C., et al.
Publicado: (1995) -
Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)